Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OPINION
September 1, 2008
- Nippon Kayaku to Support Growth by Proprietary Micellar Technology
September 1, 2008
- R&D NEWS IN BRIEF
September 1, 2008
- Takeda to Become One of the Top-Three Oncology Companies: President Hasegawa
September 1, 2008
- Kyorin Obtains Encouraging PIIa Results with KRP-104
September 1, 2008
- Nisshin Seifun Withdraws from Ethical Drug Business by Selling Joint Venture to Kyorin
September 1, 2008
- AZ, SCC to Help Elimination of Drug Lag through Joint Research
September 1, 2008
- EAD to Prepare Industry-Friendly Environment: New Director Kinoshita
August 25, 2008
- JODA Introduces Voluntary GL on Sale of OTC Drugs Online
August 25, 2008
- Mr Masuzoe Reappointed Health Minister
August 25, 2008
- Seven & i, Ain to Tie Up in Operating Dispensing Pharmacies
August 25, 2008
- COMMENTARY／1st Qtr Business Wrap-up for Top-Four Domestic Pharmas
August 25, 2008
- BUSINESS NEWS IN BRIEF
August 25, 2008
- Wholesalers' SGA Expense Ratio Drops to below 7% for the First Time
August 25, 2008
- Eliminating Losses due to Invoice Prices Higher than Sales Prices Is Not Easy: Mr Matsutani
August 25, 2008
- SSP Aims at Growth Rate 2 Points Above Industry Average: President Hatori
August 25, 2008
- Price Settlement Rate Reaches 53% as of July 31: Mediceo Paltac
August 25, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 25, 2008
- Price Settlement Rates as of End of June Similar to Those Reported 2 Years Ago
August 25, 2008
- 13th ACCJ Media Lectures
August 25, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…